Keyword: Ipilimumab , Drug Eruptions , Stevens-Johnson Syndrome , Practice Guidelines as Topic , Dipeptidyl-Peptidase IV Inhibitors , Nivolumab pp.8-14
Published Date 2016/12/12
DOI https://doi.org/10.24733/J01268.2017114083

Copyright© 2016 KYOWA KIKAKU Ltd. all rights reserved.

基本情報

電子版ISSN 2434-0340 印刷版ISSN 0387-7531 協和企画

関連文献

もっと見る

文献を共有